These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 11283049)
21. Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. Bardhan KD; Dillon J; Axon AT; Cooper BT; Tildesley G; Wyatt JI; Gatz G; Braun W Aliment Pharmacol Ther; 2000 Jan; 14(1):59-67. PubMed ID: 10632646 [TBL] [Abstract][Full Text] [Related]
22. Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection. Wu CJ; Hsu PI; Lo GH; Lo CC; Lin CK; Shie CB; Peng NJ; Tseng HH; Jou HS; Tsai PM; Chen A; Chen JL; Lai KH J Chin Med Assoc; 2004 Apr; 67(4):161-7. PubMed ID: 15244013 [TBL] [Abstract][Full Text] [Related]
23. Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week. Abdul Aal GM; Dajani AI; Nounou M; Awad S; Abdul Rasheed Z; Gautam S; Ukabam S; Nayal S Digestion; 1999; 60(3):286-97. PubMed ID: 10343145 [TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP; Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170 [TBL] [Abstract][Full Text] [Related]
25. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942 [TBL] [Abstract][Full Text] [Related]
26. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial. Svoboda P; Kantorová I; Ochmann J; Doubek J; Kozumplík L; Marsová J Hepatogastroenterology; 1997; 44(15):886-90. PubMed ID: 9222709 [TBL] [Abstract][Full Text] [Related]
27. Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success. Boixeda D; Martín De Argila C; Bermejo F; López Sanromán A; Hernández Ranz F; García Plaza A Rev Esp Enferm Dig; 2003 Mar; 95(3):206-9, 202-5. PubMed ID: 12760710 [TBL] [Abstract][Full Text] [Related]
28. One-week triple regime therapy consisting of pantoprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori-associated upper gastrointestinal diseases. Dajani AI; Awad S; Ukabam S; Nounou MA; Abdul Rasheed Z; Gautam S; Abdul Aal G; Nayal S Digestion; 1999; 60(3):298-304. PubMed ID: 10343146 [TBL] [Abstract][Full Text] [Related]
29. Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori. Ellenrieder V; Fensterer H; Waurick M; Adler G; Glasbrenner B Aliment Pharmacol Ther; 1998 Jul; 12(7):613-8. PubMed ID: 9701524 [TBL] [Abstract][Full Text] [Related]
30. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Bochenek WJ; Peters S; Fraga PD; Wang W; Mack ME; Osato MS; El-Zimaity HM; Davis KD; Graham DY; Helicobacter; 2003 Dec; 8(6):626-42. PubMed ID: 14632678 [TBL] [Abstract][Full Text] [Related]
31. Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication. Meier R; Wettstein A; Drewe J; Geiser HR; Aliment Pharmacol Ther; 2001 Jun; 15(6):851-5. PubMed ID: 11380323 [TBL] [Abstract][Full Text] [Related]
32. Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. Pilotto A; Di Mario F; Franceschi M; Leandro G; Battaglia G; Germanà B; Marin R; Valerio G Aliment Pharmacol Ther; 2000 Aug; 14(8):1077-82. PubMed ID: 10930903 [TBL] [Abstract][Full Text] [Related]
33. Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration. Dammann HG; Fölsch UR; Hahn EG; von Kleist DH; Klör HU; Kirchner T; Strobel S; Kist M Helicobacter; 2000 Mar; 5(1):41-51. PubMed ID: 10672051 [TBL] [Abstract][Full Text] [Related]
34. Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients. Pilotto A; Leandro G; Franceschi M; Bierti L; Di Battista R; Notarbartolo A; Pisciotta G; Grassi A; Crestani B; Tafner G; Michelagnoli S; Garotta F Hepatogastroenterology; 1999; 46(25):245-51. PubMed ID: 10228801 [TBL] [Abstract][Full Text] [Related]
35. [Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection]. Cui M; Hu F; Jiang H; Zheng X Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1245-8. PubMed ID: 12425803 [TBL] [Abstract][Full Text] [Related]
36. Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens. Frevel M; Daake H; Janisch HD; Kellner HU; Krezdorn HG; Tanneberger D; Wack R Aliment Pharmacol Ther; 2000 Sep; 14(9):1151-7. PubMed ID: 10971231 [TBL] [Abstract][Full Text] [Related]
37. Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. Kawabata H; Habu Y; Tomioka H; Kutsumi H; Kobayashi M; Oyasu K; Hayakumo T; Mizuno S; Kiyota K; Nakajima M; Kimoto K; Inokuchi H; Kawai K Aliment Pharmacol Ther; 2003 Jan; 17(2):259-64. PubMed ID: 12534411 [TBL] [Abstract][Full Text] [Related]
38. The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy. Eisig JN; André SB; Silva FM; Hashimoto C; Moraes-Filho JP; Laudanna AA Arq Gastroenterol; 2003; 40(1):55-60. PubMed ID: 14534667 [TBL] [Abstract][Full Text] [Related]
39. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733 [TBL] [Abstract][Full Text] [Related]
40. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection. Gawrońska-Szklarz B; Wrześniewska J; Starzyńska T; Pawlik A; Safranow K; Ferenc K; Droździk M Eur J Clin Pharmacol; 2005 Jul; 61(5-6):375-9. PubMed ID: 15976989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]